• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TX99是一种针对小鼠TIGIT的中和单克隆抗体。

TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.

作者信息

Nakamura Yuho, Naito Keisuke, Yamashita-Kanemaru Yumi, Komori Daisuke, Hirochika Rei, Shibuya Akira, Shibuya Kazuko

机构信息

1 Department of Immunology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan .

2 Life Science Center of Tsukuba Advanced Research Alliance (TARA), University of Tsukuba , Tsukuba, Japan .

出版信息

Monoclon Antib Immunodiagn Immunother. 2018 Apr;37(2):105-109. doi: 10.1089/mab.2018.0001. Epub 2018 Apr 12.

DOI:10.1089/mab.2018.0001
PMID:29648914
Abstract

T cell immunoglobulin and ITIM domains (TIGIT) is an inhibitory immunoreceptor expressed on NK cells, effector and memory T cells, and regulatory T cells (Tregs). The ligands for TIGIT are CD155 (PVR) and CD112 (PVRL2, nectin-2), which are broadly expressed on hematopoietic cells and nonhematopoietic cells. TIGIT negatively regulates antitumor responses, but promotes autoimmune reaction. Although neutralizing anti-human TIGIT mAbs are under clinical trials for cancers, how the blockade of TIGIT interaction with the ligands shows tumor immunity still remains unclear. Although analyses of mouse tumor model using a neutralizing anti-mouse TIGIT (mTIGIT) mAbs should be useful to address this issue, there are limitations to this type of studies due to unavailability of neutralizing anti-mTIGIT mAbs. In this study, we generated five clones of anti-mTIGIT mAbs, designated TX99, TX100, TX103, TX104, and TX105. We show that TX99 and TX100 showed the strongest binding to TIGIT. We also show that TX99 interfered with the interaction between TIGIT and CD155 and increased NK cell-mediated cytotoxicity against CD155-expressing RMA-S cells. Thus, TX99 is a unique neutralizing mAb that can be used for studies of mTIGIT functions.

摘要

T细胞免疫球蛋白和ITIM结构域(TIGIT)是一种抑制性免疫受体,表达于自然杀伤细胞、效应性和记忆性T细胞以及调节性T细胞(Tregs)上。TIGIT的配体是CD155(PVR)和CD112(PVRL2,nectin-2),它们广泛表达于造血细胞和非造血细胞上。TIGIT负向调节抗肿瘤反应,但促进自身免疫反应。尽管中和性抗人TIGIT单克隆抗体正在进行癌症临床试验,但TIGIT与配体相互作用的阻断如何显示肿瘤免疫仍不清楚。尽管使用中和性抗小鼠TIGIT(mTIGIT)单克隆抗体分析小鼠肿瘤模型对解决这个问题应该有用,但由于缺乏中和性抗mTIGIT单克隆抗体,这类研究存在局限性。在本研究中,我们产生了五个抗mTIGIT单克隆抗体克隆,命名为TX99、TX100、TX103、TX104和TX105。我们发现TX99和TX100与TIGIT的结合最强。我们还发现TX99干扰了TIGIT与CD155之间的相互作用,并增强了自然杀伤细胞对表达CD155的RMA-S细胞的细胞毒性。因此,TX99是一种独特的中和性单克隆抗体,可用于研究mTIGIT的功能。

相似文献

1
TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.TX99是一种针对小鼠TIGIT的中和单克隆抗体。
Monoclon Antib Immunodiagn Immunother. 2018 Apr;37(2):105-109. doi: 10.1089/mab.2018.0001. Epub 2018 Apr 12.
2
Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1.新型抗人DNAX辅助分子-1单克隆抗体的研发与特性分析
Monoclon Antib Immunodiagn Immunother. 2017 Jun;36(3):135-139. doi: 10.1089/mab.2016.0049. Epub 2017 May 12.
3
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).DNAX辅助分子-1(CD226)与其配体脊髓灰质炎病毒受体(CD155)和nectin-2(PRR-2/CD112)相互作用的功能特性
Int Immunol. 2004 Apr;16(4):533-8. doi: 10.1093/intimm/dxh059.
4
Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.当与 PVR 相互作用时,小鼠 TIGIT 抑制 NK 细胞的细胞毒性。
Eur J Immunol. 2013 Aug;43(8):2138-50. doi: 10.1002/eji.201243072. Epub 2013 Jul 4.
5
TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.TIGIT-Fc 通过促进免疫调节树突状细胞的生成来抑制 CTL 的激活,从而缓解急性移植物抗宿主病。
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):3085-3098. doi: 10.1016/j.bbadis.2018.06.022. Epub 2018 Jun 28.
6
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.IL15 刺激联合 TIGIT 阻断逆转黑色素瘤中 CD155 介导的 NK 细胞功能障碍。
Clin Cancer Res. 2020 Oct 15;26(20):5520-5533. doi: 10.1158/1078-0432.CCR-20-0575. Epub 2020 Jun 26.
7
DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.DNAM-1 与 TIGIT:在肿瘤免疫和炎症反应中的竞争作用。
Int Immunol. 2021 Nov 25;33(12):687-692. doi: 10.1093/intimm/dxab085.
8
CD155T/TIGIT Signaling Regulates CD8 T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer.CD155T/TIGIT 信号调节 CD8 T 细胞代谢并促进人胃癌的肿瘤进展。
Cancer Res. 2017 Nov 15;77(22):6375-6388. doi: 10.1158/0008-5472.CAN-17-0381. Epub 2017 Sep 7.
9
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies.T 细胞效应功能的恢复、Tregs 的耗竭和肿瘤细胞的直接杀伤:a-TIGIT 拮抗剂抗体的多种作用机制。
Mol Cancer Ther. 2021 Jan;20(1):121-131. doi: 10.1158/1535-7163.MCT-20-0464. Epub 2020 Dec 4.
10
Contribution of inhibitory receptor TIGIT to NK cell education.抑制性受体 TIGIT 对 NK 细胞发育的贡献。
J Autoimmun. 2017 Jul;81:1-12. doi: 10.1016/j.jaut.2017.04.001. Epub 2017 Apr 21.